NCT03864042 2024-09-27
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
Pfizer
Phase 1 Completed
Pfizer
Brooklyn ImmunoTherapeutics, LLC
Ipsen
Brooklyn ImmunoTherapeutics, LLC
Menarini International Operations Luxembourg SA
Takeda